Financials

  • Market Capitalization 1.33 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-8.74
주가매출액비율
941.13

Related tickers

#이름가격24h %7d %1M %1Y %마켓 캡이전 7일
2208
TSHA
Taysha Gene Therapies, Inc. - Common Stock
4.14 USD-7.80%-8.81%-17.20%-17.03%1.35 B USD
2214
ANAB
AnaptysBio, Inc. - Common Stock
46.04 USD+0.20%-6.82%-15.63%+30.80%1.34 B USD
2252
DRTS
Alpha Tau Medical Ltd. - Ordinary Shares
14.26 USD-1.04%-4.81%+1.06%+264.71%1.26 B USD
2257
GHRS
GH Research PLC - Ordinary Shares
20.02 USD-5.16%-9.94%-26.40%+41.38%1.24 B USD

뉴스